Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

William Clay Faquin, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by William Faquin and Derrick Lin.
Connection Strength

1.417
  1. Human Papillomavirus Related Multiphenotypic Sinonasal Carcinoma: Report of a Case with Early and Progressive Metastatic Disease. J Neurol Surg Rep. 2019 Oct; 80(4):e41-e43.
    View in: PubMed
    Score: 0.217
  2. Immunohistochemical quantification of partial-EMT in oral cavity squamous cell carcinoma primary tumors is associated with nodal metastasis. Oral Oncol. 2019 12; 99:104458.
    View in: PubMed
    Score: 0.216
  3. Intercalated duct lesion of the parotid. Head Neck Pathol. 2012 Sep; 6(3):373-6.
    View in: PubMed
    Score: 0.126
  4. Malignant transformation of a highly aggressive human papillomavirus type 11-associated recurrent respiratory papillomatosis. Am J Otolaryngol. 2010 Jul-Aug; 31(4):291-6.
    View in: PubMed
    Score: 0.106
  5. Case records of the Massachusetts General Hospital. Case 20-2007. An 11-year-old boy with a calcified mass in the nose. N Engl J Med. 2007 Jun 28; 356(26):2721-30.
    View in: PubMed
    Score: 0.092
  6. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin. Ann Otol Rhinol Laryngol. 2006 Jan; 115(1):59-64.
    View in: PubMed
    Score: 0.083
  7. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma. Head Neck. 2021 08; 43(8):2434-2444.
    View in: PubMed
    Score: 0.060
  8. Prospective assessment of multiple HPV-positive oropharyngeal squamous cell carcinomas. Oral Oncol. 2021 06; 117:105212.
    View in: PubMed
    Score: 0.059
  9. Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma. J Immunother Cancer. 2020 09; 8(2).
    View in: PubMed
    Score: 0.057
  10. Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy. J Natl Cancer Inst. 2019 09 01; 111(9):933-942.
    View in: PubMed
    Score: 0.053
  11. Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model. Cancer Immunol Immunother. 2019 Aug; 68(8):1273-1286.
    View in: PubMed
    Score: 0.053
  12. Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy. ORL J Otorhinolaryngol Relat Spec. 2019; 81(1):55-62.
    View in: PubMed
    Score: 0.052
  13. Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma. Oncologist. 2019 10; 24(10):1356-1367.
    View in: PubMed
    Score: 0.052
  14. Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland. JAMA Otolaryngol Head Neck Surg. 2018 11 01; 144(11):1011-1016.
    View in: PubMed
    Score: 0.050
  15. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell. 2017 Dec 14; 171(7):1611-1624.e24.
    View in: PubMed
    Score: 0.047
  16. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma. Am J Surg Pathol. 2017 Nov; 41(11):1473-1482.
    View in: PubMed
    Score: 0.047
  17. PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4+ TILs in the Presence of PD-L1+ TAMs. Cancer Res. 2017 11 15; 77(22):6365-6374.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.